FRM
TWST icon

Fox Run Management’s Twist Bioscience TWST Stock Holding History

Fox Run Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,623
Closed -$440K – 1274
2025
Q3 		$440K Buy
+15,623
New +$473K 0.07% 545
2025
Q2 		– Sell
-13,295
Closed -$522K – 1246
2025
Q1 		$522K Sell
13,295
-3,444
-21% -$155K 0.08% 473
2024
Q4 		$778K Buy
16,739
+6,138
+58% +$277K 0.14% 260
2024
Q3 		$479K Buy
10,601
+812
+8% +$38.6K 0.11% 372
2024
Q2 		$482K Buy
9,789
+522
+6% +$21.3K 0.09% 425
2024
Q1 		$318K Buy
+9,267
New +$334K 0.07% 521
2023
Q4 		– Sell
-22,255
Closed -$451K – 1028
2023
Q3 		$451K Buy
+22,255
New +$489K 0.13% 295
2023
Q2 		– Sell
-30,640
Closed -$462K – 970
2023
Q1 		$462K Buy
+30,640
New +$677K 0.15% 247
2022
Q1 		– Sell
-3,626
Closed -$281K – 706
2021
Q4 		$281K Buy
+3,626
New +$372K 0.17% 250

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Fox Run Management's TWST Position: Q4 2025 in Review

Fox Run Management sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 15,623 shares — an estimated $440K sold.

Fox Run Management first reported a position in TWST in Q4 2021 and held it in 9 quarters. The position peaked at $778K in Q4 2024. 244 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

  • Fox Run Management reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
  • Fox Run Management sold 15,623 Twist Bioscience shares in Q4 2025, an estimated $440K.
  • Fox Run Management first reported a position in Twist Bioscience in Q4 2021 and held it in 9 quarters.
  • Fox Run Management's Twist Bioscience position peaked at $778K in Q4 2024.
  • 244 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.